市场调查报告书
商品编码
1558274
到 2030 年高级伤口敷料市场预测:按产品类型、伤口类型、分销管道、最终用户和地区进行的全球分析Advanced Wound Dressings Market Forecasts to 2030 - Global Analysis By Product Type (Alginates, Collagens, Foams, Hydrocolloids, Hydrofibres, Hydrogels and Other Product Types), Wound Type, Distribution Channel, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球先进伤口敷料市场规模为 78 亿美元,预计在预测期内将以 7.6% 的复合年增长率增长,到 2030 年达到 121 亿美元。
先进的伤口敷料是一种专门的医疗材料,旨在促进复杂伤口的癒合过程。与传统敷料不同,它透过保持湿度、促进细胞迁移和预防感染为创伤治疗提供最佳环境。这些敷料通常用于慢性伤口,如糖尿病溃疡、褥疮和烧伤。它们含有水凝胶、藻酸盐、发泡体和亲水胶体等成分,具有水合作用、渗出液管理和免受外部污染物侵害等优点,可改善患者的治疗效果。
根据《伤口管理与预防》2022年发表的报导,预计到2060年,65岁及以上的老年人口将增加25.0%,对高级创伤护理的需求将持续增长。
手术次数增加
外科手术的增加推动了对先进伤口敷料的需求,因为它们是术后护理所必需的专用材料。随着手术数量的增加,对有效伤口管理解决方案的需求也在增加,以加速癒合、降低感染风险并提高患者舒适度。具有优异水分控制和保护性能的高性能伤口敷料在外科伤口管理的临床环境中越来越受到青睐,为市场成长做出了重大贡献。
恢復时间长
较长的恢復时间可能会增加医疗成本并降低患者的依从性,对市场产生负面影响。较长的癒合时间需要频繁更换敷料,这可能会导致医疗资源紧张并增加患者的财务负担。此外,长时间的康復会增加患者的不满并降低对先进创伤护理解决方案的信任。由于医疗保健提供者和患者都寻求更有效率、更具成本效益的选择,这些因素可能会减缓市场成长。
转向先进的伤口管理
医疗保健提供者越来越多地采用创新的创伤护理解决方案,以增强传统敷料的癒合能力。这种转变是由于需要更有效地管理慢性伤口、改善患者治疗效果和缩短住院时间而推动的。先进的伤口敷料因其卓越的水分管理、感染预防和促进癒合效果而被选择,从而带来显着的市场成长和创新。
高成本
高市场成本是采用的主要障碍,特别是在资源匮乏的环境。这种专用敷料的成本可能会限制患者和医疗保健提供者的可及性,并导致对更实惠的传统替代品的依赖。这些成本因素也会导致医疗保健预算紧张,并抑制先进解决方案的使用,儘管它们具有临床益处。因此,市场成长可能会受到阻碍,特别是在註重成本效益的医疗保健的地区。
COVID-19 的疫情对市场产生了各种影响。儘管择期手术和常规就诊被推迟,对创伤护理产品的需求减少,但疫情凸显了有效伤口管理在预防院内感染的重要性。儘管供应链中断和医疗支出减少最初减缓了市场成长,但在疫情期间对感染控制和家庭创伤护理的日益关注最终支持了市场復苏。
预计亲水胶体产业将成为预测期内最大的细分市场
预计亲水胶体在预测期内将占最大份额。这些敷料由果胶和明胶等凝胶形成剂组成,可吸收伤口渗出物,同时形成对污染物的保护屏障。其自黏特性和柔韧性使其非常适合伤口护理,包括褥疮和烧烫伤。由于其功效和患者舒适度,亲水胶体对亲水胶体的日益偏好正在推动市场成长。
预计医院领域在预测期内的复合年增长率最高。
预计医院领域在预测期内的复合年增长率最高。随着外科手术量的增加以及人们越来越关注减少医院感染,医院正在投资先进的创伤护理解决方案。这些敷料具有卓越的癒合特性和感染控制能力,对于改善患者治疗效果、缩短復原时间和降低整体医疗成本至关重要,从而推动市场成长。
预计北美在预测期内将占据最大的市场占有率。该地区先进的医疗基础设施和对创新创伤护理解决方案的关注进一步支持了市场扩张。随着人们对先进敷料的益处(包括促进癒合和预防感染)的认识不断提高,需求持续增长。此外,支持先进创伤护理的政府措施和报销政策也鼓舞了该地区的市场前景。
预计亚太地区在预测期内复合年增长率最高。糖尿病和肥胖等慢性病的盛行率不断上升是一个主要驱动因素。这些疾病通常会导致慢性伤口等併发症,需要先进的创伤护理解决方案。该地区医疗保健支出的增加正在推动先进创伤护理产品的采用。这种趋势在医疗基础建设发达的国家尤其明显。
According to Stratistics MRC, the Global Advanced Wound Dressings Market is accounted for $7.8 billion in 2024 and is expected to reach $12.1 billion by 2030 growing at a CAGR of 7.6% during the forecast period. Advanced wound dressings are specialized medical materials designed to enhance the healing process of complex wounds. Unlike traditional dressings, they provide an optimal environment for wound healing by maintaining moisture, promoting cell migration, and preventing infection. These dressings are typically used for chronic wounds such as diabetic ulcers, pressure sores, and burns. They may include components like hydrogels, alginates, foams, and hydrocolloids, which offer benefits such as moisture retention, exudate management, and protection from external contaminants, thereby improving patient outcomes.
According to an article published by Wound Management & Prevention in 2022, the demand for advanced wound care will continue to grow as the population older than 65 years is projected to increase by 25.0% by 2060.
Increasing surgical procedures
The rise in surgical procedures is driving the demand for advanced wound dressings, as these specialized materials are essential for post-operative care. As the number of surgeries increases, so does the need for effective wound management solutions that can promote faster healing, reduce infection risk, and improve patient comfort. Advanced wound dressings, with their superior moisture control and protective properties, are increasingly preferred in clinical settings to manage surgical wounds, contributing significantly to the growth of the market.
Long recovery times
Long recovery times can negatively impact the market by increasing healthcare costs and reducing patient compliance. Extended healing periods may lead to a higher demand for frequent dressing changes, which can strain healthcare resources and increase the financial burden on patients. Additionally, prolonged recovery can result in patient dissatisfaction and decreased trust in advanced wound care solutions. These factors may slow market growth as both healthcare providers and patients seek more efficient and cost-effective alternatives.
Shift to advanced wound management
Healthcare providers are increasingly adopting innovative wound care solutions that offer enhanced healing benefits over traditional dressings. This shift is driven by the need for more effective management of chronic wounds, improved patient outcomes, and reduced hospital stays. Advanced wound dressings, with their superior moisture control, infection prevention, and accelerated healing properties, are becoming the preferred choice, leading to substantial market growth and innovation.
High costs
High costs in the market pose a significant barrier to widespread adoption, particularly in low-resource settings. The expense of these specialized dressings can limit accessibility for patients and healthcare providers, leading to reliance on more affordable, traditional alternatives. This cost factor may also strain healthcare budgets, discouraging the use of advanced solutions despite their clinical benefits. As a result, market growth could be hampered, especially in regions where cost-effective care is a priority.
The COVID-19 pandemic had a mixed impact on the market. While elective surgeries and routine healthcare visits were delayed, reducing the demand for wound care products, the pandemic also highlighted the importance of effective wound management in preventing hospital-acquired infections. Supply chain disruptions and reduced healthcare spending initially slowed market growth, but the increasing focus on infection control and home-based wound care during the pandemic ultimately supported a recovery in the market.
The hydrocolloids segment is expected to be the largest during the forecast period
The hydrocolloids is expected to be the largest during the forecast period. These dressings, composed of gel-forming agents like pectin or gelatin, absorb wound exudate while forming a protective barrier against contaminants. Their self-adherent and flexible nature makes them ideal for treating various wound types, including pressure ulcers and burns. The rising preference for hydrocolloids, due to their effectiveness and patient comfort, is driving market growth.
The hospitals segment is expected to have the highest CAGR during the forecast period
The hospitals segment is expected to have the highest CAGR during the forecast period. With an increasing number of surgical procedures and a growing focus on reducing hospital-acquired infections, hospitals are investing in advanced wound care solutions. These dressings, with their superior healing properties and infection control, are essential in improving patient outcomes, reducing recovery times, and lowering overall healthcare costs, thus fueling market growth.
North America is projected to hold the largest market share during the forecast period. The region's advanced healthcare infrastructure and strong focus on innovative wound care solutions further support market expansion. With rising awareness of the benefits of advanced dressings, including faster healing and infection prevention, demand continues to grow. Additionally, government initiatives and reimbursement policies favoring advanced wound care contribute to the market's positive outlook in the region.
Asia Pacific is projected to witness the highest CAGR over the forecast period. The increasing incidence of chronic conditions such as diabetes and obesity is a significant driver. These diseases often lead to complications like chronic wounds, necessitating advanced wound care solutions. Increased healthcare spending in the region is facilitating the adoption of advanced wound care products. This trend is particularly notable in countries with improving healthcare infrastructure.
Key players in the market
Some of the key players in Advanced Wound Dressings market include 3M Co., B. Braun Melsungen AG, BSN Medical GmbH, Coloplast A/S, ConvaTec Group Plc, Molnlycke Health Care AB, Smith & Nephew Plc, Cardinal Health, Medline Industries, Integra Life Sciences, Advanced Medical Solutions, Argentum Medical, LLC, Fidia Farmaceutici, DeRoyal Industries, Essity, Human BioSciences Inc. and Sanara MedTech Inc.
In January 2024, Medline Industries, LP launched its first transparent wound dressing for pressure injury prevention with an aim to widen its product offerings.
In April 2024, Smith+Nephew announced a recent study to support the ALLEVYN LIFE Foam Dressing with an aim to strengthen its presence in the advanced wound management segment globally.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.